Data as of Q4 2025 (Dec 31, 2025)

Birchview Capital, LP

โ€ขCIK: 1618205โ€ขFiling: Q4 2025

**Birchview Capital, LP** manages $171M across a diversified portfolio of 68 positions. The fund exhibits concentrated exposure, with its top holdings including KLAC at $26.6M and BMY at $16.3M. Further significant allocations are noted in CMPX ($8.6M), STOK ($8.3M), and LRCX ($6.9M). This structure suggests a focused, high-conviction approach across select technology and healthcare sectors.

Total AUM
$170.8M
QoQ Performance
+29.0%
Positions
68
Top 10 Concentration
54.6%
Latest Filing
Q4 2025

Top Holdings Allocation

KLAC
BMY
CMPX
KLAC15.6%
BMY9.6%
CMPX5.0%
STOK4.8%
LRCX4.0%
OLMA3.9%
GPCR3.7%
PTGX2.8%

๐Ÿ“ˆ Biggest Buys

LRCX
LAM RESEARCH CORPORATION
NEW
4.0% of portfolio
CMPX
COMPASS THERAPEUTICS INC
+82.5%
5.0% of portfolio
OLMA
OLEMA PHARMACEUTICALS INC
+54.6%
3.9% of portfolio
SLDB
SOLID BIOSCIENCES INC
+137.7%
2.3% of portfolio
NTLA
INTELLIA THERAPEUTICS INC
+425.7%
1.7% of portfolio

๐Ÿ“‰ Biggest Sells

INBX
INHIBRX BIOSCIENCES INC
-88.3%
0.2% of portfolio
CSTL
CASTLE BIOSCIENCES INC
-27.1%
1.8% of portfolio
QURE
UNIQURE NV
-60.9%
0.4% of portfolio
PRTA
PROTHENA CORP PLC
-19.7%
2.5% of portfolio
BMY
BRISTOL-MYERS SQUIBB CO
-4.4%
9.6% of portfolio

Sector Breakdown

Other85.9%
Healthcare9.6%
Technology4.0%
Materials0.5%

๐Ÿšช Exited Positionssold since Q3 2025

AXGN
AXOGEN INC
SOLD
$2.1M
KNSA
KINIKSA PHARMACEUTICALS LTD
SOLD
$1.2M
SRRK
SCHOLAR ROCK HOLDING CORP
SOLD
$968.2K
AVTX
AVALO THERAPEUTICS INC
SOLD
$394.0K
GH
GUARDANT HEALTH INC
SOLD
$374.9K
+7 more exited positions

Changes from Q3 2025

NEW11 new positions
โ†‘19 increased
โ†“14 decreased

Historical Filings

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023